Annual CFF
-$3.96B$1.28B+24.44%
Summary
- Current Value
- As of today, GSK annual cash from financing is -$3.96B, up +24.44% on
- Historical Performance
- GSK annual cash from financing is down -293.39% over the past 3 years, up +66.68% over the past 5 years
- All-Time High Comparison
- GSK annual cash from financing is currently -180.82% below its historical high of $4.90B set on
- 3-Year Low Comparison
- GSK annual cash from financing is +34.72% above its 3-year low of -$6.07B reached on
- Sector Comparison
- GSK annual cash from financing is higher than 1.72% of companies in Healthcare sector
Cash From Financing Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual Cash From Financing | -$3.96B | +24.4% | -293.4% | +66.7% | +46.5% | |
| Quarterly Cash From Financing | $229.06M | -81.5% | +192.0% | +112.9% | +110.6% | |
| TTM Cash From Financing | -$3.17B | -13.1% | +64.9% | +74.5% | +55.2% | |
| Price | $49.81 | +33.3% | +36.4% | +27.4% | +12.0% | |
| Annual Cash From Operations | $9.62B | +23.7% | +17.9% | -1.9% | +1.4% | |
| Annual Cash From Investing | -$5.90B | -232.2% | +45.8% | -319.6% | -91.7% | |
| Annual Dividends Paid | $3.38B | +8.2% | -20.9% | -33.7% | -31.7% | |
| Annual Total Debt | $23.83B | +12.0% | -5.6% | -35.8% | +0.8% | |
| Shares Outstanding | 2.01B | -1.1% | -1.9% | -0.3% | – |
Cash From Financing Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $2.05B | N/A | -293.4% |
| 5Y | $2.05B | -293.4% | |
| All | $4.90B | -180.8% |
Cash From Financing Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$6.07B | +34.7% | |
| 5Y | -$11.89B | N/A | +66.7% |
| All | -$11.89B | +66.7% |
Cash From Financing History
FAQ
What is the current annual cash from financing of GSK?
As of today, GSK annual cash from financing is -$3.96B
What is 1-year change in GSK annual cash from financing?
GSK annual cash from financing is up +24.44% year-over-year
What is 3-year change in GSK annual cash from financing?
GSK annual cash from financing is down -293.39% over the past 3 years
How far is GSK annual cash from financing from its all-time high?
GSK annual cash from financing is currently -180.82% below its historical high of $4.90B set on December 31, 2018
How does GSK annual cash from financing rank versus sector peers?
GSK annual cash from financing is higher than 1.72% of companies in Healthcare sector
When is GSK next annual earnings release?
As of today, the next annual earnings release for GSK has not been scheduled
Quarterly CFF
$229.06M$860.28M-78.97%
Summary
- Current Value
- As of today, GSK quarterly cash from financing is $229.06M, down -78.97% on
- Historical Performance
- GSK quarterly cash from financing is down -81.53% year-over-year, up +191.96% over the past 3 years
- All-Time High Comparison
- GSK quarterly cash from financing is currently -98.03% below its historical high of $11.63B set on
- 3-Year Low Comparison
- GSK quarterly cash from financing is +105.64% above its 3-year low of -$4.06B reached on
- Sector Comparison
- GSK quarterly cash from financing is higher than 96.07% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly Cash From Financing | $229.06M | -79.0% | -81.5% | +192.0% | +112.9% | |
| Annual Cash From Financing | -$3.96B | – | +24.4% | -293.4% | +66.7% | |
| TTM Cash From Financing | -$3.17B | -46.9% | -13.1% | +64.9% | +74.5% | |
| Price | $49.81 | -14.9% | +33.3% | +36.4% | +27.4% | |
| Quarterly Cash From Operations | $1.48B | -45.9% | +4.3% | +1185.2% | +340.9% | |
| Quarterly Cash From Investing | -$1.78B | +44.0% | -12.9% | -160.8% | -2540.3% | |
| Quarterly Dividends Paid | $866.37M | +2.3% | +12.4% | +28.5% | -33.6% | |
| Quarterly Total Debt | $25.13B | +5.4% | +5.6% | -2.8% | -30.5% | |
| Shares Outstanding | 2.01B | – | -1.1% | -1.9% | -0.3% |
Quarterly Cash From Financing Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $1.24B | N/A | -81.5% |
| 3Y | $1.24B | -81.5% | |
| 5Y | $10.79B | -97.9% | |
| All | $11.63B | -98.0% |
Quarterly Cash From Financing Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$2.78B | +108.3% | |
| 3Y | -$4.06B | +105.6% | |
| 5Y | -$5.70B | +104.0% | |
| All | -$5.70B | +104.0% |
Quarterly Cash From Financing History
FAQ
What is the current quarterly cash from financing of GSK?
As of today, GSK quarterly cash from financing is $229.06M
What is GSK quarterly cash from financing most recent change?
GSK quarterly cash from financing was down -78.97% on March 31, 2026
What is 1-year change in GSK quarterly cash from financing?
GSK quarterly cash from financing is down -81.53% year-over-year
How far is GSK quarterly cash from financing from its all-time high?
GSK quarterly cash from financing is currently -98.03% below its historical high of $11.63B set on June 30, 2018
How does GSK quarterly cash from financing rank versus sector peers?
GSK quarterly cash from financing is higher than 96.07% of companies in Healthcare sector
When is GSK next earnings release?
The next earnings release for GSK is on
TTM CFF
-$3.17B$1.01B-46.93%
Summary
- Current Value
- As of today, GSK TTM cash from financing is -$3.17B, down -46.93% on
- Historical Performance
- GSK TTM cash from financing is down -13.09% year-over-year, up +64.87% over the past 3 years
- All-Time High Comparison
- GSK TTM cash from financing is currently -131.30% below its historical high of $10.11B set on
- 3-Year Low Comparison
- GSK TTM cash from financing is +65.36% above its 3-year low of -$9.14B reached on
- Sector Comparison
- GSK TTM cash from financing is higher than 1.87% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM Cash From Financing | -$3.17B | -46.9% | -13.1% | +64.9% | +74.5% | |
| Annual Cash From Financing | -$3.96B | – | +24.4% | -293.4% | +66.7% | |
| Quarterly Cash From Financing | $229.06M | -79.0% | -81.5% | +192.0% | +112.9% | |
| Price | $49.81 | -14.9% | +33.3% | +36.4% | +27.4% | |
| TTM Cash From Operations | $9.72B | +0.6% | +20.2% | +98.6% | +8.2% | |
| TTM Cash From Investing | -$7.94B | -2.6% | -154.8% | -19.3% | -391.3% | |
| TTM Dividends Paid | $3.49B | +2.8% | +8.8% | -4.0% | -32.9% | |
| Quarterly Total Debt | $25.13B | +5.4% | +5.6% | -2.8% | -30.5% | |
| Shares Outstanding | 2.01B | – | -1.1% | -1.9% | -0.3% |
TTM Cash From Financing Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$2.15B | -46.9% | |
| 3Y | -$2.15B | -46.9% | |
| 5Y | $3.19B | -199.1% | |
| All | $10.11B | -131.3% |
TTM Cash From Financing Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$4.09B | +22.6% | |
| 3Y | -$9.14B | +65.4% | |
| 5Y | -$12.43B | N/A | +74.5% |
| All | -$12.43B | +74.5% |
TTM Cash From Financing History
FAQ
What is the current TTM cash from financing of GSK?
As of today, GSK TTM cash from financing is -$3.17B
What is GSK TTM cash from financing most recent change?
GSK TTM cash from financing was down -46.93% on March 31, 2026
What is 1-year change in GSK TTM cash from financing?
GSK TTM cash from financing is down -13.09% year-over-year
How far is GSK TTM cash from financing from its all-time high?
GSK TTM cash from financing is currently -131.30% below its historical high of $10.11B set on March 31, 2019
How does GSK TTM cash from financing rank versus sector peers?
GSK TTM cash from financing is higher than 1.87% of companies in Healthcare sector
When is GSK next earnings release?
The next earnings release for GSK is on
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
Data Sources & References
- GSK Official Website www.gsk.com
- GSK Profile on Yahoo Finance finance.yahoo.com/quote/GSK
- GSK Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/gsk